{
  "company": {
    "name": "IgC Bio",
    "website": "https://igc.bio/",
    "record": "https://startuphistory.org/c/igc.bio"
  },
  "status": null,
  "history_since": null,
  "baseline": null,
  "live_captures": 0,
  "last_checked": null,
  "live_status": "js_only",
  "messaging": [],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Scala Biodesign",
      "record": "https://startuphistory.org/c/scala-bio.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both offer computational platforms that explicitly design and optimize antibodies."
    },
    {
      "name": "Ainnocence, Inc.",
      "record": "https://startuphistory.org/c/ainnocence.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both focus on de novo antibody design and protein engineering using AI platforms."
    },
    {
      "name": "Absci",
      "record": "https://startuphistory.org/c/absci.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both use generative AI to design novel antibody or biologic therapeutics in silico."
    },
    {
      "name": "immunitoAI",
      "record": "https://startuphistory.org/c/immunitoai.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both design de novo antibody therapeutics using structure‑aware AI platforms."
    },
    {
      "name": "Helixon",
      "record": "https://startuphistory.org/c/helixon.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both use AI-driven platforms to design next‑generation therapeutic antibodies."
    },
    {
      "name": "Nabla Bio",
      "record": "https://startuphistory.org/c/nabla.bio",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both run AI-driven platforms for rational antibody and protein therapeutic design."
    },
    {
      "name": "Galux",
      "record": "https://startuphistory.org/c/galux.co.kr",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both use AI for de novo antibody and protein therapeutic design."
    },
    {
      "name": "BigHat Biosciences",
      "record": "https://startuphistory.org/c/bighatbio.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both use AI-guided platforms for antibody discovery and engineering."
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “IgC Bio” company record, https://startuphistory.org/c/igc.bio"
}